Table 2.
Astrocyte molecules | Anti-inflammatory functions | Reference |
---|---|---|
Cytokines and growth factors | ||
TGFβ, IL6, IL10, IL11, IL19, IL27 | Activate diverse anti-inflammatory signaling mechanisms. | 37–39, 131–133 |
SHH | Maintains blood-brain barrier by acting on endothelia Smo receptors; Induces proliferation of scar-forming astrocytes. |
51, 134 |
Intracellular signaling factors | ||
STAT3, A20, Gal9, CRYAB | Suppress pro-inflammatory signaling mechanisms. | 26, 41, 54, 68, 69, 71, 135 |
Receptors | ||
ERα, GP130, DRD2, | Suppress pro-inflammatory signaling mechanisms. | 55, 69, 74, 75 |
Small inter-cellular effector molecules | ||
RA | Reduces oxidative stress, protects blood-brain barrier function, reduces inflammation. | 66 |
microRNAs | ||
miR-181, Dicer1, miR-17-5p | Suppress pro-inflammatory signaling mechanisms; Required for scar-forming astrocyte proliferation via JAK/STAT signaling. |
72, 136 |
Astrocyte molecules | Pro-inflammatory functions | Reference |
---|---|---|
Chemokines | ||
CCL2, CCL5, CCL7, CCL8, CCL12 | Recruit diverse leukocytes including monocytes, macrophages, T cells, eosinophils, basophils, mast cells, dendritic cells. | 37–39, 43, 44, 132 |
CXCL1, CXCL9, CXCL10, CXCL12, CXCL16 | Recruit diverse leukocytes including monocytes, macrophages, neutrophil, T cells, NKT cells, B cells, dendritic cells. | 37–39, 45, 132 |
Cytokines and growth factors | ||
IL1β, IL6, IL11, IL15, IL17, TNFα, BAFF | Activate diverse pro-inflammatory signaling mechanisms. | 37–39, 131, 132, 137 |
VEGF | Opens endothelial blood-brain barrier and promotes leukocyte extravasation. | 46, 47 |
Intracellular signaling factors | ||
NFκB, SOCS3, | Activate diverse pro-inflammatory signaling mechanisms. | 40–42 |
Act1 | Activates IL17 mediated pro-inflammatory signaling mechanisms. | |
Small inter-cellular effector molecules | ||
PGE, NO | Diverse pro-inflammatory effects. | 135 |